These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22499510)

  • 21. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.
    Choi JG; Kim HG; Kim MC; Yang WM; Huh Y; Kim SY; Oh MS
    J Ethnopharmacol; 2011 Mar; 134(2):414-21. PubMed ID: 21195155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
    Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease.
    Song S; Sava V; Rowe A; Li K; Cao C; Mori T; Sanchez-Ramos J
    Neurosci Lett; 2011 Jan; 487(2):153-7. PubMed ID: 20951187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.
    Dodd CA; Bloomquist JR; Klein BG
    Hum Exp Toxicol; 2013 Aug; 32(8):865-80. PubMed ID: 23263854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease.
    Feng G; Zhang Z; Bao Q; Zhang Z; Zhou L; Jiang J; Li S
    Biol Pharm Bull; 2014; 37(8):1301-7. PubMed ID: 24871044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
    Khan HA
    Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice.
    Byler SL; Boehm GW; Karp JD; Kohman RA; Tarr AJ; Schallert T; Barth TM
    Behav Brain Res; 2009 Mar; 198(2):434-9. PubMed ID: 19070633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A
    Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
    Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease.
    Barbiero JK; Santiago RM; Lima MM; Ariza D; Morais LH; Andreatini R; Vital MA
    Behav Brain Res; 2011 Jan; 216(1):186-92. PubMed ID: 20688106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson's disease.
    Rekha KR; Selvakumar GP
    Chem Biol Interact; 2014 Jun; 217():57-66. PubMed ID: 24768735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.